Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Utah Medical ProductsFRA:UTM -2.50%73 EV-to-FCF is 12.07 as of Aug. 27, 2026, which is 3% below its 10-year median of 12.47. GuruFocus rates FRA:UTM with a GF Score™ of 73/100 and a GF Value™ of €49.20. The stock has 8 warning signs investors should review. Among 409 Medical Devices & Instruments companies, Utah Medical Products ranks better than 77.26% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Utah Medical Products's Enterprise Value is €118.52 Mil.
Utah Medical Products's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was €9.82 Mil. Therefore, Utah Medical Products's EV-to-FCF for today is 12.07.
The historical rank and industry rank for Utah Medical Products's EV-to-FCF or its related term are showing as below:
FRA:UTM'
s EV-to-FCF Range Over the Past 10 Years
Min: -81.1 Med: 12.47 Max: 26.39
Current: 12.01
During the past 13 years, the highest EV-to-FCF of Utah Medical Products was 26.39. The lowest was -81.10. And the median was 12.47.
FRA:UTM's EV-to-FCF is ranked better than 77.26% of 409
companies
in the Medical Devices & Instruments industry
Industry Median: 24.43
vs FRA:UTM: 12.01
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Utah Medical Products (FRA:UTM) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Utah Medical Products's PE Ratio (TTM) for today is calculated as:
Utah Medical Products's share price for today is €58.50.
Utah Medical Products's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.822.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Utah Medical Products's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Utah Medical Products EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Utah Medical Products's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Utah Medical Products's EV-to-FCF falls into.
Utah Medical Products's current Enterprise Value is €118.52 Mil.
Utah Medical Products's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €9.82 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Utah Medical Products (FRA:UTM) has a EV-to-FCF of 12.07 as of Aug. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Utah Medical Products and its competitors. This is near median its historical median of 12.47. According to the industry distribution chart, Utah Medical Products ranks #93 out of 409 companies in the Medical Devices & Instruments industry, placing it in the top 22.7%.
Is Utah Medical Products' EV-to-FCF too high?
Utah Medical Products' current EV-to-FCF of 12.07 is near median its 10-year median of 12.47. The Medical Devices & Instruments industry median EV-to-FCF is 24.43. Utah Medical Products' value of 12.07 is 50.6% below this industry median. Based on the distribution chart, Utah Medical Products ranks #93 out of 409 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Utah Medical Products has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Utah Medical Products' EV-to-FCF compare to EMBC and SMTI?
According to the Medical Devices & Instruments industry distribution chart, Utah Medical Products ranks #93 out of 409 companies for EV-to-FCF. This places Utah Medical Products in the top 23% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 24.43. Utah Medical Products' value of 12.07 is 50.6% below this benchmark. While the company's 10-year median is 12.47 vs. the industry median of 24.43, Utah Medical Products has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 24.43, based on 409 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Utah Medical Products's current EV-to-FCF of 12.07 is 50.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Utah Medical Products and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 24.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Utah Medical Products's current EV-to-FCF is 12.07, which is near median its own 10-year median of 12.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Utah Medical Products stock overvalued right now?
Utah Medical Products (FRA:UTM) has a current EV-to-FCF of 12.07. The stock's GF Value™ is €49.20, compared to a current price of €58.50 — trading 18.9% above its estimated fair value. The current EV-to-FCF is 12.07, which is near median its 10-year median of 12.47 and 50.6% below the Medical Devices & Instruments industry median of 24.43. Utah Medical Products' overall GF Score™ is 73/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Utah Medical Products (FRA:UTM), the current EV-to-FCF is 12.07 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Utah Medical Products (FRA:UTM) Overvalued in 2026?
Based on GuruFocus' analysis, Utah Medical Products stock appears to be overvalued.
The current stock price of €58.50 is trading 18.9% above its estimated GF Value™ of €49.20.
Key valuation signals for FRA:UTM:
EV-to-FCF: 12.07 (near median its 10-year median of 12.47)
GF Value™: €49.20 vs. price of €58.50 (18.9% above fair value)
Industry Position: 50.6% below the Medical Devices & Instruments median (#93 of 409)
No single metric tells the full story. See the FRA:UTM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
73GF Score
Get the complete analysis for FRA:UTM
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:UTM has been successfully added to your 
